Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Overview of attention for article published in Journal of Clinical Oncology, May 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 44 news outlets
blogs: 16 blogs
policy: 1 policy source
twitter: 98 X users
patent: 93 patents
facebook: 13 Facebook pages

wikipedia: 10 Wikipedia pages
googleplus: 4 Google+ users
reddit: 8 Redditors
f1000: 1 research highlight platform
guideline: 8 clinical guideline sources
podcasts: 1 podcast

Readers on

mendeley: 1571 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 8 Reddit threads by 8 users.

مصادر:_...

User Jealous_Pack_9446, in the Al3almoon subreddit, 04 Dec 2025

مصادر:_ https://www.nature.com/articles/s41392-023-01407-6?utm_source=chatgpt.com https://pubmed.ncbi.nlm.nih.gov/26014293/ …

I have no idea how to pronounce this drug, but the FDA approved it last week. Here's the pivotal phase 3 trial.

User Blockhouse, in the Pharmacy subreddit, 12 Nov 2015

I have done some digging to the publication and found [the...

User Dr-Dysentery, in the World News subreddit, 04 Nov 2015

I have done some digging to the publication and found [the article](http://www.ncbi.nlm.nih.gov/pubmed/26014293) (abstract only…

Here is a link to the journal article for the original...

User docxman, in the Reddit Science subreddit, 29 Oct 2015

Here is a link to the journal article for the original research: http://jco.ascopubs.org/content/33/25/2780

This page shows the most recent Reddit threads that mention this research output. Click here to find out how to access more activity, including 4 additional Reddit threads.